BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29506074)

  • 21. Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.
    Puckett SE; Reese KA; Mitev GM; Mullen V; Johnson RC; Pomraning KR; Mellbye BL; Tilley LD; Iversen PL; Freitag M; Geller BL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6147-53. PubMed ID: 22985881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae.
    Holloway AJ; Yu J; Arulanandam BP; Hoskinson SM; Eaves-Pyles T
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
    Pichardo C; Rodríguez-Martínez JM; Pachón-Ibañez ME; Conejo C; Ibáñez-Martínez J; Martínez-Martínez L; Pachón J; Pascual A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3311-6. PubMed ID: 16048941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Characteristic of Virulence, Biofilm and Antibiotic Resistance of
    Wang G; Zhao G; Chao X; Xie L; Wang H
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32872324
    [No Abstract]   [Full Text] [Related]  

  • 25. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capsular Polysaccharide Types and Virulence-Related Traits of Epidemic KPC-Producing Klebsiella pneumoniae Isolates in a Chinese University Hospital.
    Liu Y; Liu PP; Wang LH; Wei DD; Wan LG; Zhang W
    Microb Drug Resist; 2017 Oct; 23(7):901-907. PubMed ID: 28437231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nosocomial, Multidrug-Resistant Klebsiella pneumoniae Strains Isolated from Mexico City Produce Robust Biofilms on Abiotic Surfaces but Not on Human Lung Cells.
    Ostria-Hernandez ML; Juárez-de la Rosa KC; Arzate-Barbosa P; Lara-Hernández A; Sakai F; Ibarra JA; Castro-Escarpulli G; Vidal JE
    Microb Drug Resist; 2018 May; 24(4):422-433. PubMed ID: 28915364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.
    Panchal RG; Geller BL; Mellbye B; Lane D; Iversen PL; Bavari S
    Nucleic Acid Ther; 2012 Oct; 22(5):316-22. PubMed ID: 22978365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency of multidrug-resistant (MDR) Klebsiella pneumoniae harboring several β-lactamase and integron genes collected from several hospitals in the north of Iran.
    Farhadi M; Ahanjan M; Goli HR; Haghshenas MR; Gholami M
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):70. PubMed ID: 34583687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising strategies for future treatment of
    de Oliveira Júnior NG; Franco OL
    Future Microbiol; 2020 Jan; 15():63-79. PubMed ID: 32048525
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic Diversity, Antimicrobial Resistance Pattern, and Biofilm Formation in
    Ghanizadeh A; Najafizade M; Rashki S; Marzhoseyni Z; Motallebi M
    Biomed Res Int; 2021; 2021():2347872. PubMed ID: 34957300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH
    J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains.
    Vuotto C; Longo F; Pascolini C; Donelli G; Balice MP; Libori MF; Tiracchia V; Salvia A; Varaldo PE
    J Appl Microbiol; 2017 Oct; 123(4):1003-1018. PubMed ID: 28731269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates.
    Hou XH; Song XY; Ma XB; Zhang SY; Zhang JQ
    Braz J Microbiol; 2015; 46(3):759-68. PubMed ID: 26413058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics.
    Ribeiro SM; de la Fuente-Núñez C; Baquir B; Faria-Junior C; Franco OL; Hancock RE
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3906-12. PubMed ID: 25896694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
    Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
    J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.
    Harada Y; Morinaga Y; Kaku N; Nakamura S; Uno N; Hasegawa H; Izumikawa K; Kohno S; Yanagihara K
    Clin Microbiol Infect; 2014 Nov; 20(11):O831-9. PubMed ID: 24813594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
    Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H
    Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity of cinnamaldehyde against multidrug-resistant Klebsiella pneumoniae: an in vitro and in vivo study.
    Vaz MSM; de Almeida de Souza GH; Dos Santos Radai JA; Fraga TL; de Oliveira GG; Wender H; da Silva KE; Simionatto S
    Braz J Microbiol; 2023 Sep; 54(3):1655-1664. PubMed ID: 37392293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.